About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
Symbol
Name
ID
Alb
albumin
MGI:87991
80 phenotypes from multigenic genotypes
Export: Excel File
Allelic Composition
Genetic Background
Annotated Term Reference
Albem12Mvw/Albem12Mvw
Fcgrttm1Dcr/Fcgrttm1Dcr
Tg(FCGRT)32Dcr/Tg(FCGRT)32Dcr
B6.Cg-Tg(FCGRT)32Dcr Albem12Mvw Fcgrttm1Dcr/MvwJ
decreased circulating serum albumin level J:101977
Albtm1(cre/ERT2)Mtz/Alb+
Krastm4Tyj/Kras+
Ptentm2Mak/Ptentm2Mak
involves: 129P2/OlaHsd * 129S2/SvPas * 129S4/SvJae
increased cholangiocarcinoma incidence J:254370
increased hepatocellular carcinoma incidence J:254370
Albtm1(cre/ERT2)Mtz/Alb+
Gt(ROSA)26Sortm1(Notch1)Dam/Gt(ROSA)26Sor+
involves: 129S2/SvPas * 129S4/SvJaeSor * C57BL/6
increased cholangiocarcinoma incidence J:192740
Albtm1(cre/ERT2)Mtz/Alb+
Per2tm1Jt/Per2+
Smg6tm1.1Tac/Smg6tm1.1Tac
involves: 129S2/SvPas * 129S6/SvEvTac * C57BL/6J
abnormal circadian behavior phase J:342742
abnormal circardian behavior entrainment J:342742
abnormal locomotor circadian rhythm J:342742
prolonged circadian behavior period J:342742
Albtm1(cre/ERT2)Mtz/Alb+
Nr5a2tm1Sjns/Nr5a2tm1Sjns
involves: 129/Sv * 129S2/SvPas * C57BL/6 * SJL
abnormal bile salt level J:129068
abnormal feces composition J:129068
abnormal intestinal lipid absorption J:129068
increased bile salt level J:129068
Albtm1(cre/ERT2)Mtz/Alb+
Hes1tm1Kag/Hes1tm1Kag
involves: 129S2/SvPas * C57BL/6 * CBA
normal neoplasm J:192740
Albtm1(cre/ERT2)Mtz/Alb+
Fth1tm1.1Lck/Fth1tm1.1Lck
involves: 129/Sv * C57BL/6 * SJL
abnormal liver iron level J:166515
normal liver/biliary system phenotype J:166515
Albtm1(cre/ERT2)Mtz/Alb+
Hcfc1tm1Lwh/Hcfc1+
involves: 129S2/SvPas * C57BL/6
impaired liver regeneration J:231596
Albtm1(cre/ERT2)Mtz/Alb+
Polr2mtm1.1Rgr/Polr2mtm1.1Rgr
Trp53tm1Tyj/Trp53tm1Tyj
involves: 129S2/SvPas * C57BL/6
increased hepatocyte karyomegaly J:291184
increased hepatocyte proliferation J:291184
Albtm1(cre/ERT2)Mtz/Albtm1(cre/ERT2)Mtz
Slc2a2tm2Thor/Slc2a2tm2Thor
involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6
abnormal bile salt level J:197607
abnormal circulating glucose level J:197607
abnormal glucose homeostasis J:197607
abnormal glycogen homeostasis J:197607
abnormal lipid homeostasis J:197607
decreased cellular glucose uptake J:197607
decreased insulin secretion J:197607
decreased liver cholesterol level J:197607
decreased liver triglyceride level J:197607
normal homeostasis/metabolism phenotype J:197607
impaired glucose tolerance J:197607
increased liver glycogen level J:197607
increased muscle cell glucose uptake J:197607
G6pc1tm1.1Ics/G6pc1tm1.1Ics
Albtm1(cre/ERT2)Mtz/Alb+
involves: 129S2/SvPas * C57BL/6J
abnormal blood homeostasis J:195257
abnormal hepatocyte morphology J:195257
enlarged liver J:195257
hepatic steatosis J:195257
normal homeostasis/metabolism phenotype J:195257
increased blood uric acid level J:195257
increased circulating cholesterol level J:195257
increased circulating triglyceride level J:195257
increased liver adenoma incidence J:195257
increased liver glycogen level J:195257
increased liver triglyceride level J:195257
increased liver weight J:195257
pale liver J:195257
Gt(ROSA)26Sortm2(OVA/EGFP)Dwir/Gt(ROSA)26Sor+
Albtm1(cre/ERT2)Mtz/Alb+
involves: 129P2/OlaHsd * 129S2/SvPas
abnormal hepatocyte physiology J:173806
Gt(ROSA)26Sortm2(OVA/EGFP)Dwir/Gt(ROSA)26Sor+
Tg(TcraTcrb)1100Mjb/0
Albtm1(cre/ERT2)Mtz/Alb+
involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6
increased circulating alanine transaminase level J:173806
Mir32em1Gpt/Mir32em1Gpt
Albem1(icre)Gpt/Alb+
C57BL/6JGpt-Mir32em1Gpt Albem1(icre)Gpt
abnormal lipid metabolism J:344660
abnormal liver physiology J:344660
normal behavior/neurological phenotype J:344660
decreased circulating alanine transaminase level J:344660
decreased circulating aspartate transaminase level J:344660
decreased circulating cholesterol level J:344660
decreased circulating LDL cholesterol level J:344660
decreased endoplasmic reticulum stress J:344660
decreased liver cholesterol level J:344660
decreased liver triglyceride level J:344660
decreased liver weight J:344660
decreased susceptibility to diet-induced hepatic steatosis J:344660
normal growth/size/body region phenotype J:344660
normal homeostasis/metabolism phenotype J:344660
improved glucose tolerance J:344660
increased insulin sensitivity J:344660
Mob1atm1.1Asuz/Mob1atm1.1Asuz
Mob1bGt(CC0690)Wtsi/Mob1bGt(CC0690)Wtsi
Albtm1(cre/ERT2)Mtz/Alb+
involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6
increased hepatobiliary system tumor incidence J:228499
Orc1tm1.1Gle/Orc1tm1.1Gle
Albtm1(cre/ERT2)Mtz/Alb+
involves: 129S2/SvPas * C57BL/6 * SJL
normal cellular phenotype J:272584
decreased hepatocyte number J:272584
increased hepatocyte karyomegaly J:272584
normal liver/biliary system phenotype J:272584
polyploidy J:272584
Slc2a9tm1.1Thor/Slc2a9+
Albtm1(cre/ERT2)Mtz/Alb+
involves: 129S2/SvPas * C57BL/6 * C57BL/6N
increased urine magnesium level J:153089
increased urine phosphate level J:153089
Slc2a9tm1.1Thor/Slc2a9tm1.1Thor
Albtm1(cre/ERT2)Mtz/Alb+
involves: 129S2/SvPas * C57BL/6 * C57BL/6N
decreased urine osmolality J:153089
decreased urine pH J:153089
increased blood uric acid level J:153089
increased urine magnesium level J:153089
increased urine phosphate level J:153089
increased urine potassium level J:153089
polyuria J:153089
normal renal/urinary system phenotype J:153089
uraturia J:153089
Uri1tm1.1Ndj/Uri1+
Albtm1(cre/ERT2)Mtz/Alb+
B6.Cg-Albtm1(cre/ERT2)Mtz Uri1tm1.1Ndj
abnormal enzyme/coenzyme level J:217463
decreased incidence of tumors by chemical induction J:217463
decreased susceptibility to injury J:217463
Uri1tm1.1Ndj/Uri1tm1.1Ndj
Albtm1(cre/ERT2)Mtz/Alb+
B6.Cg-Albtm1(cre/ERT2)Mtz Uri1tm1.1Ndj
abnormal liver morphology J:217463
hepatic necrosis J:217463
increased circulating alanine transaminase level J:217463
increased hepatocyte apoptosis J:217463
liver failure J:217463
liver hemorrhage J:217463
liver inflammation J:217463
postnatal lethality J:217463
Ywhabem1Gpt/Ywhabem1Gpt
Albem1(icre)Gpt/Alb+
C57BL/6JGpt-Ywhabem1Gpt Albem1(icre)Gpt
decreased liver glycogen level J:323777
enhanced gluconeogenesis J:323777
impaired glucose tolerance J:323777
increased circulating glucose level J:323777

Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
04/16/2024
MGI 6.23
The Jackson Laboratory